Literature DB >> 2785233

Immunocytochemical localization of epidermal growth factor in the developing human respiratory system and in acute and chronic lung disease in the neonate.

M T Stahlman1, D N Orth, M E Gray.   

Abstract

Cells staining for immunoreactive human epidermal growth factor were sought in the lungs and tracheas of human fetuses from 8 to 24 weeks of gestation. Lungs of liveborn infants from 25 to 40 weeks of gestation (stillborn to 7 months postnatal life), both with and without lung pathology, were also studied. In the early fetal trachea (12 to 15 weeks), many nonciliated cells immunostained for immunoreactive human epidermal growth factor in the lining epithelium. By 16 weeks of gestation this widespread staining was replaced by stained nonciliated single cells or small clusters of cells which were identifiable until 24 weeks. In the few tracheas which were available from liveborn infants who died without evidence of lung disease, stained cells were seldom identified in the lining epithelium after 24 weeks of gestation. In contrast, from 18 weeks until term, tracheal submucosal glands contained scattered cells which immunostained for immunoreactive human epidermal growth factor but which did not appear to be classical mucous cells. Beginning at 20 weeks of gestation, positively staining cells were found occasionally in bronchial lining epithelium, but more often in bronchial submucosal glands. Immunostained cells were never identified in bronchiolar epithelium in normal fetal or newborn lungs. In liveborn infants from 24 weeks onward who developed lung disease, many tracheas were severely damaged. In the presence of extensive denudation of the mucosa or the development of squamous metaplasia, immunostained cells were rarely seen in the lining epithelium. However, even under these conditions stained glandular cells could usually be identified. Stained cells were also present in the necks of those tracheal glands from which new epithelial lining cells appeared to be migrating onto denuded surfaces. Immunostained cells in the bronchial lining epithelium of infants with chronic lung disease were infrequent, just as they were in the fetus, but bronchial submucosal glands contained positively stained cells similar to those in tracheal glands. The appearance and distribution of immunostained cells were similar in the tracheal and bronchial submucosal glands in both normal subjects and those with all stages of lung disease. In contrast to the bronchioles of fetuses and infants without lung pathology, the bronchiolar epithelium of infants with chronic lung disease contained immunostained cells. Immunostained cells were found in areas of migrating dysplastic cells in relining conducting airways.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2785233

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  20 in total

1.  Postnatal lung function and morphology in transgenic mice expressing transforming growth factor-alpha.

Authors:  W D Hardie; M D Bruno; K M Huelsman; H S Iwamoto; P E Carrigan; G D Leikauf; J A Whitsett; T R Korfhagen
Journal:  Am J Pathol       Date:  1997-10       Impact factor: 4.307

2.  Ultrastructural anomalies in the fetal small intestine indicate that fetal swallowing is important for normal development: an experimental study.

Authors:  J F Trahair; R Harding
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

Review 3.  Function and regulation of expression of pulmonary surfactant-associated proteins.

Authors:  T E Weaver; J A Whitsett
Journal:  Biochem J       Date:  1991-01-15       Impact factor: 3.857

Review 4.  Signaling pathways in the epithelial origins of pulmonary fibrosis.

Authors:  William D Hardie; James S Hagood; Vrushank Dave; Anne-Karina T Perl; Jeffrey A Whitsett; Thomas R Korfhagen; Stephan Glasser
Journal:  Cell Cycle       Date:  2010-07-03       Impact factor: 4.534

5.  Inhibition of the αvβ6 integrin leads to limited alteration of TGF-α-induced pulmonary fibrosis.

Authors:  Satish K Madala; Thomas R Korfhagen; Stephanie Schmidt; Cynthia Davidson; Ramakrishna Edukulla; Machiko Ikegami; Shelia M Violette; Paul H Weinreb; Dean Sheppard; William D Hardie
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-02-07       Impact factor: 5.464

6.  Altered intestinal development after jejunal ligation in fetal sheep.

Authors:  J F Trahair; H F Rodgers; J C Cool; W D Ford
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

7.  Apoptosis is a major pathway responsible for the resolution of type II pneumocytes in acute lung injury.

Authors:  R H Bardales; S S Xie; R F Schaefer; S M Hsu
Journal:  Am J Pathol       Date:  1996-09       Impact factor: 4.307

8.  Respiratory epithelial cell expression of human transforming growth factor-alpha induces lung fibrosis in transgenic mice.

Authors:  T R Korfhagen; R J Swantz; S E Wert; J M McCarty; C B Kerlakian; S W Glasser; J A Whitsett
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

9.  Genomic profile of matrix and vasculature remodeling in TGF-alpha induced pulmonary fibrosis.

Authors:  William D Hardie; Thomas R Korfhagen; Maureen A Sartor; Adrienne Prestridge; Mario Medvedovic; Timothy D Le Cras; Machiko Ikegami; Scott C Wesselkamper; Cynthia Davidson; Maggie Dietsch; William Nichols; Jeffrey A Whitsett; George D Leikauf
Journal:  Am J Respir Cell Mol Biol       Date:  2007-05-11       Impact factor: 6.914

10.  Mig-6 is required for appropriate lung development and to ensure normal adult lung homeostasis.

Authors:  Nili Jin; Sung-Nam Cho; M Gabriela Raso; Ignacio Wistuba; Yvonne Smith; Yanan Yang; Jonathan M Kurie; Rudolph Yen; Christopher M Evans; Thomas Ludwig; Jae-Wook Jeong; Francesco J DeMayo
Journal:  Development       Date:  2009-08-26       Impact factor: 6.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.